Trial Profile
Double-Blinded Comparative Study to Investigate the Efficacy and Safety of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride in Patients With T2DM Inadequately Treated With Constant Dose of Glimepiride.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2011
Price :
$35
*
At a glance
- Drugs Glimepiride/metformin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jun 2009 New trial record